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signals from a pulsed proton beam (about 5 pC/pulse, 6 µs 
FWHM) and detector shifts down to 2 mm. The measured 
relative shifts of the Bragg peak position of 2.3 mm for 1 MeV 
energy change and 173.25 mm for 82 MeV are in perfect 
agreement with Geant4 predictions. However, the low signal 
amplitude below 1 mV required an averaging with 1024 
acquisitions. 
Conclusion: Measuring the ionoacoustic signal at the IBA 
synchro-cyclotron, the detectability of 2 mm range shifts 
could be demonstrated. Experimental upgrades will be 
discussed, from which we reasonably assume to improve the 
resolution to 1 mm and below. In order to determine an 
absolute ion range in water in future ionoacoustic 
experiments, a method using an additional ultrasound 
transducer to measure the distance of the hydrophone to the 
water surface was developed. Remaining challenges on signal 
detectability for clinical dose rates as well as perspectives of 
future setup improvements will be discussed. 
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Purpose: Online in vivo control of the ion range in a patient 
during proton therapy is a major challenge for quality 
assurance of treatments. After measurements showed that 
prompt-γ emission is correlated to the ion range (Min et al 
2006, Testa et al 2008), prompt-γ imaging emerged as a 
promising method (Verburg et al 2013). Fast methods are 
required to compute accurate prompt-γ emission maps to 
design and predict the camera response from treatment 
plans. An analytic computation method based on the 
structure of the dose calculation engines in treatment 
planning system has recently been proposed (Sterpin et al 
2015). An alternative technique based on variance reduction 
in Monte Carlo (MC) calculations is developed here for 
computing prompt-γ emission maps in proton therapy.  
Materials/Methods: The track length estimator (TLE) method 
is a standard variance reduction technique in voxel-based 
dose computation in the kerma approximation (Williamson 
1987), and similar approaches have also been developed for 
positron emitter distributions in proton therapy (Parodi et al 
2007). A specific track length estimator has been developed 
here to design a continuous process along the proton track 
that locally deposits the expected value of the prompt-γ 
emission (induced by proton inelastic scattering) that would 
have occurred if a large number of protons with the same 
incident energy had followed the same step (i.e. track 
element). First an elemental database of prompt-γ emission 
spectra is established in the clinical energy range of incident 
protons for all elements in the composition of human tissues. 
This database of the prompt-γ spectra is built offline with 
high statistics. Regarding the implementation of the prompt-
γ TLE MC tally, each proton deposits along its track the 
expectation of the prompt-γ spectra from the database 
according to the proton kinetic energy and the local material 
density and composition. All software developments have 
been carried out with the Gate/Geant4 toolkit. 
Results: A detailed statistical analysis is reported to 
characterize the dependency of the variance reduction on 
the geometrical (track length distribution) and physical 
(linear prompt-γ spectrum database) parameters. 
Benchmarking of the proposed technique with respect to an 
analogous MC technique is carried out. A large relative 
efficiency gain is reported, ca. 105. Such an efficiency gain 
could reduce the MC computing time of a full treatment from 
some weeks to less than one hour. Implementation issues are 
also addressed. 
Conclusions: This MC-based technique makes it possible to 
deal with complex situations such as heterogeneities for 
which proton straggling and secondary protons may have a 
decisive contribution. When considering translation to clinic, 
measurements for the prompt-γ spectrum database, or at 
least a sound calibration protocol of the simulated prompt-γ 
spectra, will have to be carried out. 
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Since the gastrin-releasing peptide receptor(GRPR) has been 
shown to be overexpressed in prostate cancer, bombesin 
which is the ligand of GRPR has been investigated to be a 
successful candidate for the peptide receptor 
radiotherapy(PRRT)[1]. The present study describes the 
imaging and therapeutic efficacy of the theranostic 
twins(68Ga/177Lu)-labeled bombesin derivatives for the PRRT 
of GRPR-overexpressing prostate tumors. 
A series of DOTA-conjugated bombesin derivatives were 
synthesized using a solid-phase synthesis. Competitive 
binding studies were performed for selecting a GRPR-
targeting peptide with high affinity. The selected peptide 
was labeled with 68Ga using the NaCl method for imaging[2], 
and labeled with 177Lu which was produced by the HANARO 
research reactor (thermal neutron flux of 1.8 × 1014 n·cm-2·s-
1) for therapy. The labeling yield was evaluated by iTLC-SG, 
and the PET/CT imaging and therapeutic efficacy of the 
radiolabeled peptides were evaluated using nude mice 
bearing PC-3 human prostate carcinoma xenograft. 
Hydrophilic-modified bombesin derivative showed a 
nanomolar binding affinity for GRPR. The peptide was labeled 
with the both radionuclides in high incorporation 
yields(>98%). 68Ga-labeled peptide was quickly cleared from 
the blood and clearly visualized in PC-3 tumors at 1 hr p.i. 
177Lu-labeled peptide were also rapidly accumulated in a PC-3 
tumor, and the % ID/g of the tumor was 12.42 ± 2.15 1 hr p.i. 
The radio-peptide significantly inhibited the tumor growth 
